BACKGROUND: Withdrawal from chronic ethanol enhances ventral tegmental area (VTA) GABA neuron excitability and reduces mesolimbic dopamine (DA) neurotransmission, which is suppressed by acupuncture at Shenmen (HT7) points (Zhao et al., 2006). The aim of this study was to evaluate the effects of HT7 acupuncture on VTA GABA neuron excitability, ethanol inhibition of VTA GABA neuron firing rate, and ethanol self-administration. A role for opioid receptors (ORs) in ethanol and acupuncture effects is also explored. METHODS: Using electrophysiological methods in mature rats, we evaluated the effects of HT7 stimulation and opioid antagonists on VTA GABA neuron firing rate. Using behavioral paradigms in rats, we evaluated the effects of HT7 stimulation and opioid antagonists on ethanol self-administration using a modification of the sucrose-fading procedure. RESULTS: HT7 stimulation produced a biphasic modulation of VTA GABA neuron firing rate characterized by transient enhancement followed by inhibition and subsequent recovery in 5 minutes. HT7 inhibition of VTA GABA neuron firing rate was blocked by systemic administration of the nonselective μ-opioid receptor antagonist naloxone. HT7 stimulation significantly reduced ethanol suppression of VTA GABA neuron firing rate, which was also blocked by naloxone. HT7 acupuncture reduced ethanol self-administration without affecting sucrose consumption. Systemic administration of the δ-opioid receptor (DOR) antagonist naltrindole blocked ethanol suppression of VTA GABA neuron firing rate and significantly reduced ethanol self-administration without affecting sucrose consumption. CONCLUSIONS: These findings suggest that DOR-mediated opioid modulation of VTA GABA neurons may mediate acupuncture's role in modulating mesolimbic DA release and suppressing the reinforcing effects of ethanol.
BACKGROUND: Withdrawal from chronic ethanol enhances ventral tegmental area (VTA) GABA neuron excitability and reduces mesolimbic dopamine (DA) neurotransmission, which is suppressed by acupuncture at Shenmen (HT7) points (Zhao et al., 2006). The aim of this study was to evaluate the effects of HT7 acupuncture on VTA GABA neuron excitability, ethanol inhibition of VTA GABA neuron firing rate, and ethanol self-administration. A role for opioid receptors (ORs) in ethanol and acupuncture effects is also explored. METHODS: Using electrophysiological methods in mature rats, we evaluated the effects of HT7 stimulation and opioid antagonists on VTA GABA neuron firing rate. Using behavioral paradigms in rats, we evaluated the effects of HT7 stimulation and opioid antagonists on ethanol self-administration using a modification of the sucrose-fading procedure. RESULTS:HT7 stimulation produced a biphasic modulation of VTA GABA neuron firing rate characterized by transient enhancement followed by inhibition and subsequent recovery in 5 minutes. HT7 inhibition of VTA GABA neuron firing rate was blocked by systemic administration of the nonselective μ-opioid receptor antagonist naloxone. HT7 stimulation significantly reduced ethanol suppression of VTA GABA neuron firing rate, which was also blocked by naloxone. HT7 acupuncture reduced ethanol self-administration without affecting sucrose consumption. Systemic administration of the δ-opioid receptor (DOR) antagonist naltrindole blocked ethanol suppression of VTA GABA neuron firing rate and significantly reduced ethanol self-administration without affecting sucrose consumption. CONCLUSIONS: These findings suggest that DOR-mediated opioid modulation of VTA GABA neurons may mediate acupuncture's role in modulating mesolimbic DA release and suppressing the reinforcing effects of ethanol.
Authors: Roberto I Melendez; Zachary A Rodd-Henricks; Eric A Engleman; Ting-Kai Li; William J McBride; James M Murphy Journal: Alcohol Clin Exp Res Date: 2002-03 Impact factor: 3.455
Authors: Scott C Steffensen; Christine H Walton; David M Hansen; Jordan T Yorgason; Roger A Gallegos; Jose R Criado Journal: Pharmacol Biochem Behav Date: 2008-10-29 Impact factor: 3.533
Authors: Harry L June; Rancia Cummings; William J A Eiler; Katrina L Foster; Peter F McKay; Regat Seyoum; Marin Garcia; Shannan McCane; Collette Grey; Stephanie E Hawkins; Dynesha Mason Journal: Neuropsychopharmacology Date: 2004-02 Impact factor: 7.853
Authors: Nam Jun Kim; Yeonhee Ryu; Bong Hyo Lee; Suchan Chang; Yu Fan; Young S Gwak; Chae Ha Yang; Kyle B Bills; Scott C Steffensen; Jin Suk Koo; Eun Young Jang; Hee Young Kim Journal: Addict Biol Date: 2018-01-23 Impact factor: 4.280
Authors: Seong Shoon Yoon; Eun Jin Yang; Bong Hyo Lee; Eun Young Jang; Hee Young Kim; Sun-Mi Choi; Scott C Steffensen; Chae Ha Yang Journal: Psychopharmacology (Berl) Date: 2012-03-29 Impact factor: 4.530
Authors: Pei Chen; Jing Li; Xiao Han; Dennis Grech; Ming Xiong; Alex Bekker; Jiang-Hong Ye Journal: Int J Physiol Pathophysiol Pharmacol Date: 2018-03-10
Authors: Seol Ah Kim; Bong Hyo Lee; Jong Han Bae; Kwang Joong Kim; Scott C Steffensen; Yeon-Hee Ryu; Joong Woo Leem; Chae Ha Yang; Hee Young Kim Journal: PLoS One Date: 2013-11-18 Impact factor: 3.240